Medplus Subsidiary Receives Drug License Suspension Order
Medplus Health Services Limited announced that Optival Health Solutions Private Limited, a subsidiary, has received a suspension order for a Drug License affecting one of its stores. The order, issued on March 21, 2026, pertains to a store located on Guthal Road in Mandya, Karnataka.The Assistant Director, Drugs Control Administration, Mandya Circle-Mandya Karnataka, issued the order, suspending the Drug License for a period of three days. The suspension is based on a violation of Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945.
Medplus estimates the potential revenue loss associated with the suspension to be Rs 0.37 lacs.
Further details are available on the company's website at www.medplusindia.com, as well as on the websites of the BSE Limited (www.bseindia.com) and the National Stock Exchange of India Ltd. (www.nseindia.com).
The announcement was made by Manoj Kumar Srivastava, Company Secretary & Compliance Officer, of Medplus Health Services Limited.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.